BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6684724)

  • 1. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.
    Wilcken DE; Reddy SG; Gupta VJ
    Metabolism; 1983 Apr; 32(4):363-70. PubMed ID: 6684724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.
    Boers GH; Fowler B; Smals AG; Trijbels FJ; Leermakers AI; Kleijer WJ; Kloppenborg PW
    Hum Genet; 1985; 69(2):164-9. PubMed ID: 3972418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency.
    Dudman NP; Wilcken DE
    Clin Chim Acta; 1983 Jan; 127(1):105-13. PubMed ID: 6825304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
    Lu YH; Cheng LM; Huang YH; Lo MY; Wu TJ; Lin HY; Hsu TR; Niu DM
    Clin Nutr; 2015 Dec; 34(6):1155-8. PubMed ID: 25516282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients.
    Reddy GS; Wilcken DE
    Metabolism; 1982 Aug; 31(8):778-83. PubMed ID: 7098848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine response to methionine challenge in four obligate heterozygotes for homocystinuria and relationship with cystathionine beta-synthase mutations.
    Sperandeo MP; Candito M; Sebastio G; Rolland MO; Turc-Carel C; Giudicelli H; Dellamonica P; Andria G
    J Inherit Metab Dis; 1996; 19(3):351-6. PubMed ID: 8803779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.
    Boers GH; Smals AG; Trijbels FJ; Fowler B; Bakkeren JA; Schoonderwaldt HC; Kleijer WJ; Kloppenborg PW
    N Engl J Med; 1985 Sep; 313(12):709-15. PubMed ID: 4033695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
    Wilcken DE; Dudman NP; Tyrrell PA
    Metabolism; 1985 Dec; 34(12):1115-21. PubMed ID: 3934499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.
    Guttormsen AB; Ueland PM; Kruger WD; Kim CE; Ose L; Følling I; Refsum H
    Am J Med Genet; 2001 May; 100(3):204-13. PubMed ID: 11343305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of heterozygotes for homocystinuria. Study of sulphur-containing amino acids in plasma and urine after L-methionine loading.
    Sardharwalla IB; Fowler B; Robins AJ; Komrower GM
    Arch Dis Child; 1974 Jul; 49(7):553-9. PubMed ID: 4851308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine and coronary heart disease. Is slight or moderate homocysteinemia related to increased risk of coronary heart disease?].
    Donner MG; Schwandt P; Richter WO
    Fortschr Med; 1997 Jul; 115(20-21):24-30. PubMed ID: 9333583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria.
    Tsai MY; Garg U; Key NS; Hanson NQ; Suh A; Schwichtenberg K
    Atherosclerosis; 1996 Apr; 122(1):69-77. PubMed ID: 8724113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency.
    Brattström L; Israelsson B; Lindgärde F; Hultberg B
    Metabolism; 1988 Feb; 37(2):175-8. PubMed ID: 3340005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.
    Wilcken DE; Wilcken B; Dudman NP; Tyrrell PA
    N Engl J Med; 1983 Aug; 309(8):448-53. PubMed ID: 6877313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria.
    Wiley VC; Dudman NP; Wilcken DE
    Metabolism; 1988 Feb; 37(2):191-5. PubMed ID: 3340007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine in venous thromboembolism.
    Brattström L; Tengborn L; Lagerstedt C; Israelsson B; Hultberg B
    Haemostasis; 1991; 21(1):51-7. PubMed ID: 1864556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystathionine-beta-synthase deficiency: detection of heterozygotes by the ratios of homocysteine to cysteine and folate.
    Boddie AM; Steen MT; Sullivan KM; Pasquali M; Dembure PP; Coates RJ; Elsas LJ
    Metabolism; 1998 Feb; 47(2):207-11. PubMed ID: 9472972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
    Wilcken DE; Wilcken B
    J Clin Invest; 1976 Apr; 57(4):1079-82. PubMed ID: 947949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients.
    Boers GH; Smals AG; Drayer JI; Trijbels FJ; Leermakers AI; Kloppenborg PW
    Metabolism; 1983 Apr; 32(4):390-7. PubMed ID: 6621374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfur amino acids and atherosclerosis: a role for excess dietary methionine.
    Selhub J; Troen AM
    Ann N Y Acad Sci; 2016 Jan; 1363():18-25. PubMed ID: 26647293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.